Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy.

@article{Naruse2005TherapeuticNU,
  title={Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy.},
  author={Keiko Naruse and Yoji Hamada and Eitaro Nakashima and Koichi Kato and Ryuichi Mizubayashi and Hideki Kamiya and Yukio Yuzawa and Seiichi Matsuo and Toyoaki Murohara and Tatsuaki Matsubara and Yutaka Oiso and Jiro Nakamura},
  journal={Diabetes},
  year={2005},
  volume={54 6},
  pages={1823-8}
}
Diabetic neuropathy is based on the impairment of nerve blood flow and the metabolic disorder. Although the vasodilating agents and anticoagulants improve nerve function and symptoms in diabetic neuropathy, more effective treatments are needed. Because endothelial progenitor cells (EPCs) have been identified in adult human peripheral blood, many studies have shown that transplantation of EPCs improves circulation to ischemic tissues. In this study, we have demonstrated that therapeutic… CONTINUE READING

5 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Therapeutic neovascularization using cord blood - derived endothelial progenitor cells for diabetic neuropathy .
Therapeutic neovascularization using cord blood - derived endothelial progenitor cells for diabetic neuropathy .
Diabetic neuropathy is based on the impairment of nerve blood flow and the metabolic disorder .
Diabetic neuropathy is based on the impairment of nerve blood flow and the metabolic disorder .
All Topics